Petrolatum: Barrier repair and antimicrobial responses underlying this "inert" moisturizer

Journal of Allergy and Clinical Immunology

Volumn 137, Issue 4, 2016, Pages 1091-1102.e7

  Czarnowicki, Tali ^a   Malajian, Dana ^a,b   Khattri, Saakshi ^a,c   Correa da Rosa, Joel ^a   Dutt, Riana ^a,c   Finney, Robert ^d   Dhingra, Nikhil ^c   Xiangyu, Peng ^a,c   Xu, Hui ^a,c   Estrada, Yeriel D ^c   Zheng, Xiuzhong ^a   Gilleaudeau, Patricia ^a   Sullivan Whalen, Mary ^a   Suaréz Fariñas, Mayte ^a,c   Shemer, Avner ^e   Krueger, James G ^a   Guttman Yassky, Emma ^a,c  

^a ROCKEFELLER UNIVERSITY   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e SHEBA MEDICAL CENTER   (Israel)

Author keywords

antimicrobial peptides; atopic dermatitis; barrier; innate immunity; moisturizer; occlusion; patch tests; Petrolatum; skin surgeries

Indexed keywords

BETA DEFENSIN 2; CALGRANULIN A; CALGRANULIN B; FILAGGRIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LORICRIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PETROLATUM; TIPRELESTAT; WHITE PETROLATUM; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; EMOLLIENT AGENT; INTERMEDIATE FILAMENT PROTEIN; MEMBRANE PROTEIN;

ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKINFOLD THICKNESS; STRATUM CORNEUM; UPREGULATION; VERY ELDERLY; ADOLESCENT; CASE CONTROL STUDY; CLINICAL TRIAL; DERMATITIS, ATOPIC; DRUG EFFECTS; IMMUNOLOGY; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; SKIN; YOUNG ADULT;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; BIOMARKERS; CASE-CONTROL STUDIES; DERMATITIS, ATOPIC; EMOLLIENTS; FEMALE; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PETROLATUM; SKIN; YOUNG ADULT;

EID: 84945561210     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.08.013     Document Type: Article

References (105)

1. Chesebrough RA, inventor. Improvement in products from petroleum. US patent US127568. June 4, 1872.
2. I. Jakasa, S. Kezic, and P.J. Boogaard Dermal uptake of petroleum substances Toxicol Lett 235 2015 123 139
3. M. Lodén The increase in skin hydration after application of emollients with different amounts of lipids Acta Derm Venereol 72 1992 327 330
4. M. Lodén, and E. Barany Skin-identical lipids versus petrolatum in the treatment of tape-stripped and detergent-perturbed human skin Acta Derm Venereol 80 2000 412 415
5. R. Ghadially, L. Halkier-Sorensen, and P.M. Elias Effects of petrolatum on stratum corneum structure and function J Am Acad Dermatol 26 1992 387 396
6. A.V. Rawlings, D.A. Canestrari, and B. Dobkowski Moisturizer technology versus clinical performance Dermatol Ther 17 suppl 1 2004 49 56
7. R.I. Nijhawan, L.A. Smith, and K. Mariwalla Mohs surgeons' use of topical emollients in postoperative wound care Dermatol Surg 39 2013 1260 1263
8. D.P. Smack, A.C. Harrington, C. Dunn, R.S. Howard, A.J. Szkutnik, S.J. Krivda, and et al. Infection and allergy incidence in ambulatory surgery patients using white petrolatum vs bacitracin ointment. A randomized controlled trial JAMA 276 1996 972 977
9. K.A. Zug, A.K. Pham, D.V. Belsito, J.G. DeKoven, V.A. DeLeo, J.F. Fowler Jr., and et al. Patch testing in children from 2005 to 2012: results from the North American contact dermatitis group Dermatitis 25 2014 345 355
10. J.E. Fraki, L. Peltonen, and V.K. Hopsu-Havu Allergy to various components of topical preparations in stasis dermatitis and leg ulcer Contact Dermatitis 5 1979 97 100
11. W.D. James Use of antibiotic-containing ointment versus plain petrolatum during and after clean cutaneous surgery J Am Acad Dermatol 55 2006 915 916
12. K. Greenberg, J. Espinosa, and V. Scali Anaphylaxis to topical bacitracin ointment Am J Emerg Med 25 2007 95 96
13. J.A. Saryan, T.C. Dammin, and A.E. Bouras Anaphylaxis to topical bacitracin zinc ointment Am J Emerg Med 16 1998 512 513
14. J.F. Schechter, R.D. Wilkinson, and J. Del Carpio Anaphylaxis following the use of bacitracin ointment. Report of a case and review of the literature Arch Dermatol 120 1984 909 911
15. M.A. Vale, A. Connolly, A.M. Epstein, and M.R. Vale Bacitracin-induced anaphylaxis Arch Dermatol 114 1978 800
16. M. Suaréz-Fariñas, S.J. Tintle, A. Shemer, A. Chiricozzi, K. Nograles, I. Cardinale, and et al. Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities J Allergy Clin Immunol 127 2011 954 964 e1-4
17. E.A. Holm, H.C. Wulf, L. Thomassen, and G.B. Jemec Instrumental assessment of atopic eczema: validation of transepidermal water loss, stratum corneum hydration, erythema, scaling, and edema J Am Acad Dermatol 55 2006 772 780
18. I. Jakasa, M.M. Verberk, M. Esposito, J.D. Bos, and S. Kezic Altered penetration of polyethylene glycols into uninvolved skin of atopic dermatitis patients J Invest Dermatol 127 2007 129 134
19. M.C. Winge, T. Hoppe, B. Berne, A. Vahlquist, M. Nordenskjold, M. Bradley, and et al. Filaggrin genotype determines functional and molecular alterations in skin of patients with atopic dermatitis and ichthyosis vulgaris PLoS One 6 2011 e28254
20. D. Malajian, and D.V. Belsito Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis J Am Acad Dermatol 69 2013 232 237
21. T. Czarnowicki, J.G. Krueger, and E. Guttman-Yassky Skin barrier and immune dysregulation in atopic dermatitis: an evolving story with important clinical implications J Allergy Clin Immunol Pract 2 2014 371 381
22. P.Y. Ong, T. Ohtake, C. Brandt, I. Strickland, M. Boguniewicz, T. Ganz, and et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis N Engl J Med 347 2002 1151 1160
23. E. Christophers, and T. Henseler Contrasting disease patterns in psoriasis and atopic dermatitis Arch Dermatol Res 279 suppl 1987 S48 S51
24. E. Guttman-Yassky, M.A. Lowes, J. Fuentes-Duculan, L.C. Zaba, I. Cardinale, K.E. Nograles, and et al. Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis J Immunol 181 2008 7420 7427
25. D.W. Miller, S.B. Koch, B.A. Yentzer, A.R. Clark, J.R. O'Neill, J. Fountain, and et al. An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial J Drugs Dermatol 10 2011 531 537
26. G. Pennick, S. Harrison, D. Jones, and A.V. Rawlings Superior effect of isostearyl isostearate on improvement in stratum corneum water permeability barrier function as examined by the plastic occlusion stress test Int J Cosmet Sci 32 2010 304 312
27. T. Matsumoto, H. Yuasa, R. Kai, H. Ueda, S. Ogura, and Y. Honda Skin capacitance in normal and atopic infants, and effects of moisturizers on atopic skin J Dermatol 34 2007 447 450
28. S. Seite, G.E. Flores, J.B. Henley, R. Martin, H. Zelenkova, L. Aguilar, and et al. Microbiome of affected and unaffected skin of patients with atopic dermatitis before and after emollient treatment J Drugs Dermatol 13 2014 1365 1372
29. E.L. Simpson, J.R. Chalmers, J.M. Hanifin, K.S. Thomas, M.J. Cork, W.H. McLean, and et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention J Allergy Clin Immunol 134 2014 818 823
30. K. Horimukai, K. Morita, M. Narita, M. Kondo, H. Kitazawa, M. Nozaki, and et al. Application of moisturizer to neonates prevents development of atopic dermatitis J Allergy Clin Immunol 134 2014 824 830.e6
31. R. Ghadially, B.E. Brown, S.M. Sequeira-Martin, K.R. Feingold, and P.M. Elias The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model J Clin Invest 95 1995 2281 2290
32. E. Guttman-Yassky, M. Suaréz-Fariñas, A. Chiricozzi, K.E. Nograles, A. Shemer, J. Fuentes-Duculan, and et al. Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis J Allergy Clin Immunol 124 2009 1235 1244.e58
33. N. Dhingra, A. Shemer, J. Correa da Rosa, M. Rozenblit, J. Fuentes-Duculan, J.K. Gittler, and et al. Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response J Allergy Clin Immunol 134 2014 362 372
34. M. Suaréz-Fariñas, N. Dhingra, J. Gittler, A. Shemer, I. Cardinale, C. de Guzman Strong, and et al. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis J Allergy Clin Immunol 132 2013 361 370
35. J.K. Gittler, A. Shemer, M. Suaréz-Fariñas, J. Fuentes-Duculan, K.J. Gulewicz, C.Q. Wang, and et al. Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis J Allergy Clin Immunol 130 2012 1344 1354
36. K.E. Nograles, L.C. Zaba, A. Shemer, J. Fuentes-Duculan, I. Cardinale, T. Kikuchi, and et al. IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells J Allergy Clin Immunol 123 2009 1244 1252.e2
37. E. Guttman-Yassky, M.A. Lowes, J. Fuentes-Duculan, J. Whynot, I. Novitskaya, I. Cardinale, and et al. Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis J Allergy Clin Immunol 119 2007 1210 1217
38. S. Tintle, A. Shemer, M. Suaréz-Fariñas, H. Fujita, P. Gilleaudeau, M. Sullivan-Whalen, and et al. Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response J Allergy Clin Immunol 128 2011 583 593 e1-4
39. F. Bose, L. Petti, M. Diani, C. Moscheni, S. Molteni, A. Altomare, and et al. Inhibition of CCR7/CCL19 axis in lesional skin is a critical event for clinical remission induced by TNF blockade in patients with psoriasis Am J Pathol 183 2013 413 421
40. X. Yin, H. Cheng, R. Zhang, X. Fan, F. Zhou, L. Jiang, and et al. Combined effect of five single nucleotide polymorphisms related to IL23/Th17 pathway in the risk of psoriasis Immunogenetics 66 2014 215 218
41. C.W. Li, H.G. Lu, H. Chen de, Z.B. Lin, Y. Wang de, and T.Y. Li In vivo and in vitro studies of Th17 response to specific immunotherapy in house dust mite-induced allergic rhinitis patients PLoS One 9 2014 e91950
42. M.J. Burton, and C.J. Doree Interventions for recurrent idiopathic epistaxis (nosebleeds) in children Cochrane Database Syst Rev 1 2004 CD004461
43. A.B. Fleischer Jr., S.R. Feldman, R.E. White, B. Leshin, and R. Byington Procedures for skin diseases performed by physicians in 1993 and 1994: analysis of data from the National Ambulatory Medical Care Survey J Am Acad Dermatol 37 1997 719 724
44. M.T. Gette, J.G. Marks Jr., and M.E. Maloney Frequency of postoperative allergic contact dermatitis to topical antibiotics Arch Dermatol 128 1992 365 367
45. H. Jenssen, P. Hamill, and R.E. Hancock Peptide antimicrobial agents Clin Microbiol Rev 19 2006 491 511
46. D.M. Bowdish, and R.E. Hancock Anti-endotoxin properties of cationic host defence peptides and proteins J Endotoxin Res 11 2005 230 236
47. R.E. Hancock Peptide antibiotics Lancet 349 1997 418 422
48. J. Schauber, and R.L. Gallo Antimicrobial peptides and the skin immune defense system J Allergy Clin Immunol 124 suppl 2 2009 R13 R18
49. D.M. Hoover, K.R. Rajashankar, R. Blumenthal, A. Puri, J.J. Oppenheim, O. Chertov, and et al. The structure of human beta-defensin-2 shows evidence of higher order oligomerization J Biol Chem 275 2000 32911 32918
50. S.H. White, W.C. Wimley, and M.E. Selsted Structure, function, and membrane integration of defensins Curr Opin Struct Biol 5 1995 521 527
51. M. Frohm, B. Agerberth, G. Ahangari, M. Stahle-Backdahl, S. Liden, H. Wigzell, and et al. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders J Biol Chem 272 1997 15258 15263
52. M.H. Braff, and R.L. Gallo Antimicrobial peptides: an essential component of the skin defensive barrier Curr Top Microbiol Immunol 306 2006 91 110
53. L.J. Zhang, C.F. Guerrero-Juarez, T. Hata, S.P. Bapat, R. Ramos, M.V. Plikus, and et al. Innate immunity. Dermal adipocytes protect against invasive Staphylococcus aureus skin infection Science 347 2015 67 71
54. S. Krishna, and L.S. Miller Innate and adaptive immune responses against Staphylococcus aureus skin infections Semin Immunopathol 34 2012 261 280
55. S. Ryu, P.I. Song, C.H. Seo, H. Cheong, and Y. Park Colonization and infection of the skin by S. aureus: immune system evasion and the response to cationic antimicrobial peptides Int J Mol Sci 15 2014 8753 8772
56. J. Harder, J. Bartels, E. Christophers, and J.M. Schroder A peptide antibiotic from human skin Nature 387 1997 861
57. P. Brandtzaeg, T.O. Gabrielsen, I. Dale, F. Muller, M. Steinbakk, and M.K. Fagerhol The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces Adv Exp Med Biol 371A 1995 201 206
58. K.T. Miyasaki, A.L. Bodeau, A.R. Murthy, and R.I. Lehrer In vitro antimicrobial activity of the human neutrophil cytosolic S-100 protein complex, calprotectin, against Capnocytophaga sputigena J Dent Res 72 1993 517 523
59. D. Lusitani, S.E. Malawista, and R.R. Montgomery Calprotectin, an abundant cytosolic protein from human polymorphonuclear leukocytes, inhibits the growth of Borrelia burgdorferi Infect Immun 71 2003 4711 4716
60. A.R. Murthy, R.I. Lehrer, S.S. Harwig, and K.T. Miyasaki In vitro candidastatic properties of the human neutrophil calprotectin complex J Immunol 151 1993 6291 6301
61. R. Glaser, J. Harder, H. Lange, J. Bartels, E. Christophers, and J.M. Schroder Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection Nat Immunol 6 2005 57 64
62. Z. Hegyi, S. Zwicker, D. Bureik, M. Peric, S. Koglin, A. Batycka-Baran, and et al. Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 "alarmins" psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis J Invest Dermatol 132 2012 1416 1424
63. M. Niebuhr, D. Mamerow, A. Heratizadeh, I. Satzger, and T. Werfel Staphylococcal alpha-toxin induces a higher T cell proliferation and interleukin-31 in atopic dermatitis Int Arch Allergy Immunol 156 2011 412 415
64. K. Wolk, H. Mitsui, K. Witte, S. Gellrich, N. Gulati, D. Humme, and et al. Deficient cutaneous antibacterial competence in cutaneous T-cell lymphomas: role of Th2-mediated biased Th17 function Clin Cancer Res 20 2014 5507 5516
65. N. Dhingra, M. Suaréz-Fariñas, J. Fuentes-Duculan, J.K. Gittler, A. Shemer, A. Raz, and et al. Attenuated neutrophil axis in atopic dermatitis compared to psoriasis reflects TH17 pathway differences between these diseases J Allergy Clin Immunol 132 2013 498 501.e3
66. N. Isailovic, K. Daigo, A. Mantovani, and C. Selmi Interleukin-17 and innate immunity in infections and chronic inflammation J Autoimmun 60 2015 1 11
67. F. Shen, Z. Hu, J. Goswami, and S.L. Gaffen Identification of common transcriptional regulatory elements in interleukin-17 target genes J Biol Chem 281 2006 24138 24148
68. M. Goupil, V. Cousineau-Cote, F. Aumont, S. Senechal, L. Gaboury, Z. Hanna, and et al. Defective IL-17- and IL-22-dependent mucosal host response to Candida albicans determines susceptibility to oral candidiasis in mice expressing the HIV-1 transgene BMC Immunol 15 2014 49
69. S.C. Liang, X.Y. Tan, D.P. Luxenberg, R. Karim, K. Dunussi-Joannopoulos, M. Collins, and et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides J Exp Med 203 2006 2271 2279
70. H. Fujita The role of IL-22 and Th22 cells in human skin diseases J Dermatol Sci 72 2013 3 8
71. J.M. Reynolds, P. Angkasekwinai, and C. Dong IL-17 family member cytokines: regulation and function in innate immunity Cytokine Growth Factor Rev 21 2010 413 423
72. J. Correa da Rosa, D. Malajian, A. Shemer, M. Rozenblit, N. Dhingra, T. Czarnowicki, and et al. Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin J Allergy Clin Immunol 135 2015 712 720
73. N. Dhingra, N. Gulati, and E. Guttman-Yassky Mechanisms of contact sensitization offer insights into the role of barrier defects vs. intrinsic immune abnormalities as drivers of atopic dermatitis J Invest Dermatol 133 2013 2311 2314
74. J.A. Warner, L.Y. McGirt, and L.A. Beck Biomarkers of Th2 polarity are predictive of staphylococcal colonization in subjects with atopic dermatitis Br J Dermatol 160 2009 183 185
75. H.Y. Park, C.R. Kim, I.S. Huh, M.Y. Jung, E.Y. Seo, J.H. Park, and et al. Staphylococcus aureus colonization in acute and chronic skin lesions of patients with atopic dermatitis Ann Dermatol 25 2013 410 416
76. P.M. Elias, and J.S. Wakefield Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis J Allergy Clin Immunol 134 2014 781 791.e1
77. P.M. Elias, Y. Hatano, and M.L. Williams Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms J Allergy Clin Immunol 121 2008 1337 1343
78. J. van Smeden, M. Janssens, G.S. Gooris, and J.A. Bouwstra The important role of stratum corneum lipids for the cutaneous barrier function Biochim Biophys Acta 1841 2014 295 313
79. S.M. Sa, P.A. Valdez, J. Wu, K. Jung, F. Zhong, L. Hall, and et al. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis J Immunol 178 2007 2229 2240
80. I. Nomura, E. Goleva, M.D. Howell, Q.A. Hamid, P.Y. Ong, C.F. Hall, and et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes J Immunol 171 2003 3262 3269
81. L.A. Beck, D. Thaci, J.D. Hamilton, N.M. Graham, T. Bieber, R. Rocklin, and et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis N Engl J Med 371 2014 130 139
82. K. Boniface, F.X. Bernard, M. Garcia, A.L. Gurney, J.C. Lecron, and F. Morel IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes J Immunol 174 2005 3695 3702
83. K.E. Nograles, L.C. Zaba, E. Guttman-Yassky, J. Fuentes-Duculan, M. Suaréz-Fariñas, I. Cardinale, and et al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways Br J Dermatol 159 2008 1092 1102
84. M.D. Howell, B.E. Kim, P. Gao, A.V. Grant, M. Boguniewicz, A. DeBenedetto, and et al. Cytokine modulation of atopic dermatitis filaggrin skin expression J Allergy Clin Immunol 124 suppl 2 2009 R7 R12
85. L. Pellerin, J. Henry, C.Y. Hsu, S. Balica, C. Jean-Decoster, M.C. Mechin, and et al. Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin J Allergy Clin Immunol 131 2013 1094 1102
86. J. Seltmann, L.M. Roesner, F.W. von Hesler, M. Wittmann, and T. Werfel IL-33 impacts on the skin barrier by downregulating the expression of filaggrin J Allergy Clin Immunol 135 2015 1659 1661.e4
87. E. Gros, S. Petzold, L. Maintz, T. Bieber, and N. Novak Reduced IFN-gamma receptor expression and attenuated IFN-gamma response by dendritic cells in patients with atopic dermatitis J Allergy Clin Immunol 128 2011 1015 1021
88. T. Czarnowicki, J. Gonzalez, A. Shemer, D. Malajian, H. Xu, X. Zheng, and et al. Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population J Allergy Clin Immunol 136 2015 104 115.e7
89. R.A. Mathias, A. Weinberg, M. Boguniewicz, D.J. Zaccaro, B. Armstrong, L.C. Schneider, and et al. Atopic dermatitis complicated by eczema herpeticum is associated with HLA B7 and reduced interferon-gamma-producing CD8+ T cells Br J Dermatol 169 2013 700 703
90. L. Bin, M.G. Edwards, R. Heiser, J.E. Streib, B. Richers, C.F. Hall, and et al. Identification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum J Allergy Clin Immunol 134 2014 848 855
91. J. van Smeden, M. Janssens, E.C. Kaye, P.J. Caspers, A.P. Lavrijsen, R.J. Vreeken, and et al. The importance of free fatty acid chain length for the skin barrier function in atopic eczema patients Exp Dermatol 23 2014 45 52
92. M. Janssens, J. van Smeden, G.S. Gooris, W. Bras, G. Portale, P.J. Caspers, and et al. Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients J Lipid Res 53 2012 2755 2766
93. W.M. Macharia, G.M. Anabwani, and D.M. Owili Effects of skin contactants on evolution of atopic dermatitis in children: a case control study Trop Doct 21 1991 104 106
94. E.L. Simpson, T.M. Berry, P.A. Brown, and J.M. Hanifin A pilot study of emollient therapy for the primary prevention of atopic dermatitis J Am Acad Dermatol 63 2010 587 593
95. M. Glatz, E. Polley, E. Simpson, and H. Kong Emollient therapy alters skin barrier and microbes in infants at risk for developing atopic dermatitis [abstract] J Invest Dermatol 135 suppl 2015 S31
96. G.F. Sonnenberg, L.A. Fouser, and D. Artis Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22 Nat Immunol 12 2011 383 390
97. S. Eyerich, K. Eyerich, A. Cavani, and C. Schmidt-Weber IL-17 and IL-22: siblings, not twins Trends Immunol 31 2010 354 361
98. H. Ishigame, S. Kakuta, T. Nagai, M. Kadoki, A. Nambu, Y. Komiyama, and et al. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses Immunity 30 2009 108 119
99. J.S. Cho, E.M. Pietras, N.C. Garcia, R.I. Ramos, D.M. Farzam, H.R. Monroe, and et al. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice J Clin Invest 120 2010 1762 1773
100. S.Y. Liu, D.J. Sanchez, R. Aliyari, S. Lu, and G. Cheng Systematic identification of type I and type II interferon-induced antiviral factors Proc Natl Acad Sci U S A 109 2012 4239 4244
101. E.H. van den Bogaard, J.G. Bergboer, M. Vonk-Bergers, I.M. van Vlijmen-Willems, S.V. Hato, P.G. van der Valk, and et al. Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis J Clin Invest 123 2013 917 927
102. J.B. Slutsky, R.A. Clark, A.A. Remedios, and P.A. Klein An evidence-based review of the efficacy of coal tar preparations in the treatment of psoriasis and atopic dermatitis J Drugs Dermatol 9 2010 1258 1264
103. F.J. Quintana, A.S. Basso, A.H. Iglesias, T. Korn, M.F. Farez, E. Bettelli, and et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor Nature 453 2008 65 71
104. S. Trifari, C.D. Kaplan, E.H. Tran, N.K. Crellin, and H. Spits Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells Nat Immunol 10 2009 864 871
105. M. Suaréz-Fariñas, B. Ungar, J. Correa da Rosa, D.A. Ewald, M. Rozenblit, J. Gonzalez, and et al. RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications J Allergy Clin Immunol 135 2015 1218 1227